EUVIMEDEUVIMED entdecken
Crossref

CD38-specific immunoPET imaging for multiple myeloma diagnosis and therapeutic monitoring: preclinical and first-in-human studies

Wenpeng Huang, Tianyao Wang, Yongkang Qiu, Chenzhen Li, Bo Chen, Lele Song, Qi Yang, Xinyao Sun, Bing Jia, Lei Kang iD

European Journal of Nuclear Medicine and Molecular Imaging · 2025-04 · 52 (5) · 1791-1804

DOI: 10.1007/s00259-024-07036-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 27.12.2024. Verfasst von Wenpeng Huang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Peking University First Hospital, No. 8 Xishiku Str., Xicheng Dist, Beijing, 100034, China. Hauptthemen laut MEDLINE: Multiple Myeloma, ADP-ribosyl Cyclase 1, Positron-Emission Tomography, Membrane Glycoproteins. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of Chin, the Beijing Science Foundation for Distinguished Young Scholars, the Beijing Municipal Science & Technology Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaADP-ribosyl Cyclase 1Positron-Emission TomographyMembrane GlycoproteinsHumansAnimalsMiceCell Line, TumorGallium RadioisotopesPositron Emission Tomography Computed TomographySingle-Domain AntibodiesFemaleTissue Distribution

Stichwörter der Autor:innen

68GaCD38First-in-humanMultiple myelomaNanobodyPositron emission tomography

Substanzen

ADP-ribosyl Cyclase 1Gallium RadioisotopesSingle-Domain AntibodiesMembrane Glycoproteins

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Peking University First Hospital, No. 8 Xishiku Str., Xicheng Dist, Beijing, 100034, China.
  • Department of Radiation Medicine, School of Basic Medical Sciences, Peking University, Beijing, 100191, China.
  • Chengdu AlpVHHs Co. Ltd, Chengdou, 611137, China.
  • Department of Nuclear Medicine, Peking University First Hospital, No. 8 Xishiku Str., Xicheng Dist, Beijing, 100034, China. kanglei@bjmu.edu.cn.

ORCID-Profile: Lei Kang

Förderung

  • National Natural Science Foundation of Chin
  • the Beijing Science Foundation for Distinguished Young Scholars
  • the Beijing Municipal Science & Technology Commission
  • National High Level Hospital Clinical Research Funding (Interdisciplinary Research Project of Peking University First Hospital,
  • Scientific and Technological Achievements Transformation Incubation Guidance Fund Project of Peking University First Hospital
  • China Postdoctoral Science Foundation under Grant Number
  • Scientific Research Seed Fund of Peking University First Hospital
  • Beijing Nova Program

Zitieren

APA

Huang, W., Wang, T., Qiu, Y., Li, C., Chen, B., Song, L., Yang, Q., Sun, X., Jia, B., & Kang, L. (2025). CD38-specific immunoPET imaging for multiple myeloma diagnosis and therapeutic monitoring: preclinical and first-in-human studies. European Journal of Nuclear Medicine and Molecular Imaging, 52(5), 1791-1804. https://doi.org/10.1007/s00259-024-07036-7

Vancouver

Huang W, Wang T, Qiu Y, Li C, Chen B, Song L, et al. CD38-specific immunoPET imaging for multiple myeloma diagnosis and therapeutic monitoring: preclinical and first-in-human studies. European Journal of Nuclear Medicine and Molecular Imaging. 2025;52(5):1791-1804. doi:10.1007/s00259-024-07036-7

BibTeX
@article{Huang2025,
  author = {Huang, Wenpeng and Wang, Tianyao and Qiu, Yongkang and Li, Chenzhen and Chen, Bo and Song, Lele and Yang, Qi and Sun, Xinyao and Jia, Bing and Kang, Lei},
  title = {CD38-specific immunoPET imaging for multiple myeloma diagnosis and therapeutic monitoring: preclinical and first-in-human studies},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2025},
  volume = {52},
  number = {5},
  pages = {1791--1804},
  doi = {10.1007/s00259-024-07036-7}
}
Kostenlos starten →